03 - 04 October 2022 | San Diego, USA
Immuno US
03 - 04 October 2022 | San Diego, USA

Discuss the latest strategies to harness the immune system for the development of innovative therapeutics

Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.

4th Annual Advances in Immuno-Oncology USA Congress

The Congress includes...

  • Network with key innovators in Cancer Immunotherapy. 2022 Attendees included: Senior Clinical Pharmacologist, Bristol-Myers Squibb; Director, Pfizer; and Director, Novartis.
  • Hear case studies across a variety of key therapeutic strategies currently being applied in discovery and clinical research: combination therapies, T-cell strategies, checkpoint inhibitors, intra-tumoural therapies, oncolytic viruses, bispecific drugs and cancer vaccines
  • Advance your understanding of Biomarker development and the Tumour micro-environment, from spatial biology multi omic approaches to biomarker technologies like mass spectrometry, immunohistochemistry and Cytof
  • Examine the latest challenges and technological innovations in preclinical and clinical development with discussions on animal modelling techniques and screening strategies in preclinical development along with the challenges of clinical trial design
  • Unparalleled Networking Opportunities. The two-day conference offers dedicated networking opportunities such as roundtable and panel discussions, creating an interactive platform for high-level scientific and business discussions. Participate in formal or informal discussions during our networking breaks and pre-organized 1-2-1 meetings

Agenda at a Glance

Day One

Day Two

This event is co-located with our well established 6th Annual Biomarkers & Precision Medicine USA Congress.
The established event provides an additional 45+ presentations on biomarker research, with key focusses on biomarkers for
translational science, clinical development and targeted therapies.

Key Speakers

The 2022 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

The following are confirmed speakers for the 2022 event.

Jeffrey Wallin
Senior Director, Biomarker Sciences
Luke Devey
Vice President, Translational Sciences, Immunology
Ewa Carrier
Executive Director, Clinical Development
Jeffrey Skolnik
Vice President, Clinical Development
Inovio Pharmaceuticals
Jadwiga Bienkowska
Sr. Director, Computational Biology ORD
Kevin Gergich
Executive Director, Oncology Clinical Operations

Delegate Rates

Book now to take advantage of early registration rates.

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall

Networking Drinks

Relax after a busy first day at the event with access to the vibrant drinks reception

Event App

Our Event App features a personalisable agenda, peer-to-peer networking, OnDemand Presentations, solution provider content, and much more!


A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.